Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1992 1
1993 1
1994 1
1997 1
2005 2
2006 1
2007 4
2008 1
2009 3
2010 3
2011 3
2013 3
2014 4
2015 2
2016 2
2017 1
2018 5
2019 2
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Drug therapy for hereditary cancers.
Imyanitov EN, Moiseyenko VM. Imyanitov EN, et al. Among authors: moiseyenko vm. Hered Cancer Clin Pract. 2011 Aug 6;9(1):5. doi: 10.1186/1897-4287-9-5. Hered Cancer Clin Pract. 2011. PMID: 21819606 Free PMC article.
Hereditary breast-ovarian cancer syndrome in Russia.
Sokolenko AP, Iyevleva AG, Mitiushkina NV, Suspitsin EN, Preobrazhenskaya EV, Kuligina ESh, Voskresenskiy DA, Lobeiko OS, Krylova NY, Gorodnova TV, Buslov KG, Bit-Sava EM, Dolmatov GD, Porhanova NV, Polyakov IS, Abysheva SN, Katanugina AS, Baholdin DV, Yanus GA, Togo AV, Moiseyenko VM, Maximov SY, Semiglazov VF, Imyanitov EN. Sokolenko AP, et al. Among authors: moiseyenko vm. Acta Naturae. 2010 Oct;2(4):31-5. Acta Naturae. 2010. PMID: 22649661 Free PMC article.
Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome.
Moiseenko FV, Volkov NM, Zhabina AS, Stepanova ML, Rysev NA, Klimenko VV, Myslik AV, Artemieva EV, Egorenkov VV, Abduloeva NH, Ivantsov AO, Kuligina ES, Imyanitov EN, Moiseyenko VM. Moiseenko FV, et al. Among authors: moiseyenko vm. Cancer Treat Res Commun. 2022;31:100524. doi: 10.1016/j.ctarc.2022.100524. Epub 2022 Jan 31. Cancer Treat Res Commun. 2022. PMID: 35101831 Free article. Clinical Trial.
Quality of life in the trastuzumab for gastric cancer trial.
Satoh T, Bang YJ, Gotovkin EA, Hamamoto Y, Kang YK, Moiseyenko VM, Ohtsu A, Van Cutsem E, Al-Sakaff N, Urspruch A, Hill J, Weber HA, Chung HC; ToGA Trial Investigators. Satoh T, et al. Among authors: moiseyenko vm. Oncologist. 2014 Jul;19(7):712-9. doi: 10.1634/theoncologist.2014-0058. Epub 2014 Jun 20. Oncologist. 2014. PMID: 24951609 Free PMC article. Clinical Trial.
High-dose toremifene in advanced renal-cell carcinoma.
Gershanovich MM, Moiseyenko VM, Vorobjev AV, Käpylä H, Ellmén J, Anttila M. Gershanovich MM, et al. Among authors: moiseyenko vm. Cancer Chemother Pharmacol. 1997;39(6):547-51. doi: 10.1007/s002800050612. Cancer Chemother Pharmacol. 1997. PMID: 9118468 Clinical Trial.
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
Moiseyenko VM, Moiseyenko FV, Yanus GA, Kuligina ES, Sokolenko AP, Bizin IV, Kudriavtsev AA, Aleksakhina SN, Volkov NM, Chubenko VA, Kozyreva KS, Kramchaninov MM, Zhuravlev AS, Shelekhova KV, Pashkov DV, Ivantsov AO, Venina AR, Sokolova TN, Preobrazhenskaya EV, Mitiushkina NV, Togo AV, Iyevleva AG, Imyanitov EN. Moiseyenko VM, et al. Clin Drug Investig. 2018 Jun;38(6):553-562. doi: 10.1007/s40261-018-0629-1. Clin Drug Investig. 2018. PMID: 29470838
43 results